Reporting Rigor of Cancer Rehabilitation Interventions: Application of the CReDECI-2 Guidelines

Rachelle Brick1, Lauren Voss, Sasha Arbid

  • 1From the Division of Cancer Control and Population Sciences, Behavioral Research Program, Basic Biobehavioral and Psychological Sciences Research Branch, National Cancer Institute, Bethesda, Maryland (RB); University of Toronto, Faculty of Kinesiology and Physical Education, Toronto, Canada (LV); University Health Network, Princess Margaret Cancer Centre, Cancer Rehabilitation and Survivorship Program, Toronto, Canada (SA, YJ, GAT, DEH, AL, JMJ); Department of Physical Medicine and Rehabilitation, Cedars-Sinai Medical Center, Los Angeles, California (AGS); Mrs T.H. Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, California (CK); West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia (AS); Department of Occupational Therapy, Institute of Health Professions, Boston, Massachusetts (SW, KDL); Duquesne University, School of Nursing, Pittsburg, Pennsylvania; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (GC); Department of Physical Therapy, University of British Columbia, Vancouver, Canada (KLC); and Veterans Affairs, Office of Research and Development, Health Systems Research, Washington, District of Columbia (LP).

Summary

Cancer rehabilitation intervention reporting is often incomplete, hindering clinical practice translation. Future research must use reporting checklists for detailed descriptions of these vital interventions.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
678
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
756
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147